2018 MDMA Reimbursement Agenda


                    

*Speakers will be added as confirmed

Click Here for a PDF of the Agenda

Wednesday, November 7, 2018

Day one of the conference consists of interactive and intensive panels that answer how medical devices are reimbursed, what it takes to establish reimbursement, and practical advice to achieve success.  These sessions will explore the foundation of medical device reimbursement (coding coverage, and payment) as these processes intersect in the current and evolving healthcare environment, and will focus on creating an implementable strategy so a product can be commercialized.  They also include real world applications, case simulations and an idea exchange with participants to discuss product-specific reimbursement questions and issues to begin to put this information into practice. 

2:30pm - 5:00pm

Reimbursement Challenges, Case Studies, Critical Strategic Planning

  • Judy Rosenbloom, Founder & President, JR Associates
  • Lynn Saccoliti, President, Strada Medical Device Reimbursement
  • Jo Ellen Slurzberg, Vice President, Global Health Policy/Reimbursement, JR Associates

5:00pm - 6:00pm

Networking Reception

Thursday, November 8, 2018

7:30am - 8:15am

Registration & Continental Breakfast

8:15am - 8:30am 

Welcome, Opening Remarks & Introductions

  • Mark Leahey, President & CEO, MDMA

8:30am - 9:15am

Shifting from Volume to Value

As hospitals and payors adapt to new regulations and models, learn how your team needs to adjust its value-proposition, clinical trials and more to improve your ability to secure reimbursement.

  • Jo Ellen Slurzberg, Vice President, Global Health Policy/Reimbursement, JR Associates
  • Elizabeth Halpern, Partner, Hogan Lovells

9:15am - 9:45am

Finding Answers with Data: First Find the Questions

Data analysis can be helpful to answer many business questions and to support reimbursement.  There are many options for buying data, but what you really want is the answer to a problem.  Formulating the question, communicating this to the analysis team and understanding the strengths and weaknesses of the data are critical to making good decisions.  Learn ways to effectively get the data analysis you need to meet your business planning and reimbursement objectives.

  • Mary Jo Braid-Forbes, President, Braid-Forbes Health Research

9:45am - 10:15am

Networking Break

10:15am - 10:45am

CMS Ombudsman Listening Session

CMS Ombudsman James Bailey will provide an overview of the role of the ombudsman and listen to the challenges and obstacles med tech innovators face in dealing with the coding, coverage and payment processes. 

  • James Bailey, Ombudsman, Centers for Medicare & Medicaid Services, Offices of Hearings and Inquiries (OHI)

10:45am - 11:15am

CMMI Update

The Deputy Director of CMMI will provide an update and overview of the department and share what they are working on to improve value and develop new models of health care delivery.

  • Amy Bassano, Deputy Director, Centers for Medicare and Medicaid Innovation, CMS

11:15am - 12:00pm

Navigating CPT & RUC; Implications for Access

Ongoing challenges with the CPT and RUC remain a hurdle for many medical technology innovators, with serious implications for negative outcomes.  Learn the importance of aligning pursuing a CPT code with your business plan and other reimbursement components. Learn about the latest developments on how to navigate these policies, and what changes may be coming on the horizon.

  • Michael Beebe, Vice President, ADVI
  • Judy Rosenbloom, Founder & President, JR Associates

12:00pm - 1:00pm

Buffet Lunch

1:00pm - 1:45pm

Securing Coverage with CMS

Securing coverage with CMS continues to be a major hurdle for innovators, especially as private payors rely more and more on their decisions.  Leading experts will share strategies that maximize your ability to get a favorable outcome.

  • Lori Ashby, Director, Division of Policy and Evidence Review, CMS' Center for Clinical Standards and Quality's Coverage and Analysis Group
  • Elizabeth Halpern, Partner, Hogan Lovells

1:45pm - 2:30pm

Local Coverage Process

As Congress continues to examine the local coverage decision process and CMS institutes provisions from “CURES” legislation, get the latest best-practices on how your technology can successfully navigate the new landscape.

  • Ryan Graver, Sr. Vice President of Market Access, Acessa Health
  • Kelli Hallas, Executive Vice President, Emerson Consultants
  • Barb Peterson, President & CEO, Emerson Consultants

 2:30pm - 2:45pm

Networking Break

2:45pm - 3:30pm

Better Future for Evidence Development & Tech Assessment

Your ability to succeed in gaining reimbursement is directly connected to the quality of your technology’s evidence.  Top experts will share examples and answer questions on how to confront this growing focus of medtech innovation.

  • Barb Peterson, President & CEO, Emerson Consultants
  • Liz Spurgin, Vice President, Health Economics & Patient Access, MDIC

3:30pm - 4:15pm

International Reimbursement Issues

Stephen Hull will present on the leading international market issues, from Europe, to China and Japan. This presentation will address high level updates on EU regulatory changes, the development a pan-European HTA framework for devices, the simmering trade war with China, and the latest in Japanese reimbursement issues. 

  • Stephen Hull, Principal & Founder, Hull Associates

 

         

Sessions and speakers are subject to change without notice. MDMA reserves the right to cancel or reschedule any program, whereupon full registration fees will be refunded or applied to the rescheduled program in accordance with the registrant's preference. In the event of canceled programs, MDMA assumes no responsibility for transportation, hotel, or other expenses incurred by registrants.